Imunon, Inc. ·

IMNN 8-K 2026-09-29

Imunon, Inc. (IMNN) 8-K dated 2026-09-29 — accession 0001493152-26-044792. This URL is the filing, not the IMNN hub.

Imunon, Inc. (IMNN) is a biotechnology company listed on US.

Imunon, Inc. filed a 8-K on 2026-09-29. Accession 0001493152-26-044792.

Cached items: 1.01, 3.02, 5.03, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported IMNN revenue for 2022-12-31 was $500.0K. Net income was -$35.9M. IMNN currently screens at market cap $9.2M.

Not investment advice. The IMNN SEC hub lists recent forms. The stock page is the research view.

Source on EDGAR

Lician Pro $19.99/mo or $149/yr